MICROBOT MEDICAL INC. Marketable Securities, Unrealized Gain (Loss)
MICROBOT MEDICAL INC. (MBOT) reported Marketable Securities, Unrealized Gain (Loss) of $215.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-08-11
- MICROBOT MEDICAL INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-06-30 was -$7.00K.
- MICROBOT MEDICAL INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-03-31 was $222.00K.
- MICROBOT MEDICAL INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-12-31 was -$278.00K.
- MICROBOT MEDICAL INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was $163.00K.
- MICROBOT MEDICAL INC. marketable securities, unrealized gain (loss) for fiscal 2025 was $4.00K.
- MICROBOT MEDICAL INC. marketable securities, unrealized gain (loss) for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- MICROBOT MEDICAL INC. marketable securities, unrealized gain (loss) for fiscal 2023 was $59.00K, a 391.67% increase from fiscal 2022.
- MICROBOT MEDICAL INC. marketable securities, unrealized gain (loss) for fiscal 2022 was $12.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $215.00K 10-Q · filed 2026-08-11 | -$63.00K derived: sum of 3 quarters · filed 2026-08-11 | $100.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $222.00K 10-Q · filed 2026-05-13 | -$56.00K derived: sum of 2 quarters · filed 2026-05-13 | $107.00K derived: sum of 3 quarters · filed 2026-05-13 | |
| 2025-12-31 | -$278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$115.00K derived: sum of 2 quarters · filed 2026-03-26 | $4.00K 10-K · filed 2026-03-26 | |
| 2025-09-30 | $163.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $282.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $119.00K 10-Q · filed 2026-08-11 | |||
| 2024-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $2.00K 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | -$46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $24.00K derived: sum of 2 quarters · filed 2025-03-25 | $32.00K derived: sum of 3 quarters · filed 2025-03-25 | $59.00K 10-K · filed 2025-03-25 |
| 2023-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $78.00K derived: sum of 2 quarters · filed 2023-11-14 | $105.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $35.00K 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $27.00K 10-Q · filed 2023-05-17 | |||
| 2022-12-31 | $12.00K 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |